|
SLU7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.942430E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.556100E-03 |
| Normal-vs-Stage2 |
4.172800E-01 |
| Normal-vs-Stage3 |
5.498800E-01 |
| Normal-vs-Stage4 |
5.826200E-02 |
| Stage1-vs-Stage2 |
3.360000E-01 |
| Stage1-vs-Stage3 |
1.878180E-03 |
| Stage1-vs-Stage4 |
1.7164199999975E-05 |
| Stage2-vs-Stage3 |
2.226200E-01 |
| Stage2-vs-Stage4 |
4.877600E-02 |
| Stage3-vs-Stage4 |
2.435600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.909900E-02 |
| Normal-vs-AfricanAmerican |
1.136780E-01 |
| Normal-vs-Asian |
4.795200E-01 |
| Caucasian-vs-AfricanAmerican |
1.630030E-02 |
| Caucasian-vs-Asian |
7.072800E-01 |
| AfricanAmerican-vs-Asian |
1.461620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.196170E-01 |
| Normal-vs-Female |
6.403800E-01 |
| Male-vs-Female |
3.271200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.498600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.397600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.000800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.259000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.830000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.429400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.026400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.345370E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.894600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.372800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.690330E-02 |
| Normal-vs-Grade 2 |
5.799900E-03 |
| Normal-vs-Grade 3 |
3.871600E-01 |
| Normal-vs-Grade 4 |
5.557900E-03 |
| Grade 1-vs-Grade 2 |
5.603800E-01 |
| Grade 1-vs-Grade 3 |
2.169200E-01 |
| Grade 1-vs-Grade 4 |
2.195400E-03 |
| Grade 2-vs-Grade 3 |
6.718000E-02 |
| Grade 2-vs-Grade 4 |
5.7713000001236E-07 |
| Grade 3-vs-Grade 4 |
6.806400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.64830000004557E-06 |
| Normal-vs-ccB subtype |
2.000400E-01 |
| ccA subtype-vs-ccB subtype |
3.39460004550318E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.059600E-01 |
| Normal-vs-N1 |
7.040300E-02 |
| N0-vs-N1 |
1.203210E-01 |
|
|
